Background and Objective: Untrained family caregivers struggle with complicated medical management regimens for hospice patients. An intervention was tested to improve caregiver's perception of pain management and patient's pain. Design, Setting, and Participants: The intervention was tested with a 2-group (usual care vs intervention) randomized controlled trial using parallel mixed-methods analysis of 446 caregivers in 3 Midwestern hospice programs representing rural and urban settings. Intervention: Web conferencing or telephones were used to connect caregivers with the hospice care team during care plan meetings. Measurements: Caregiver's perceptions of pain management were the primary outcome. Secondary outcomes included caregiver quality of life, patient's pain, and anxiety. Video recordings, field notes, and caregiver and staff interviews provided qualitative data. Results: The overall perception of pain management was not changed by the participation in hospice team meetings. Perceptions of fatalism improved for intervention participants, and the intervention participants perceived their patients' pain was better controlled than those in the control group. The intervention was found to be feasible to deliver in rural areas. Caregiver's anxiety and patient's pain were correlated (r ¼ .18; P ¼ .003), and subanalysis indicated that caregivers of patients with cancer may benefit more from the intervention than other hospice caregivers. Qualitative analyses provided understanding of caregiver's perceptions of pain, cost, and facilitators and barriers to routine involvement of family in care plan meetings. Limitations and Conclusion: The hospice philosophy is supportive of caregiver involvement in care planning, and technology makes this feasible; the intervention needs modification to become translational as well as additional measurement to assess effectiveness. Caregiver education and emotional support should occur outside the meeting, and a strong leader should facilitate the meeting to control efficiency. Finally, the intervention may benefit caregivers of patients with cancer more than others.
Introduction
An estimated 1.5 to 1.6 million Americans were enrolled in hospice programs for care at the end of their life in 2014. 1 These patients were cared for by family members who were unpaid caregivers and who provided an average of over 20 hours of care per week to their family member. 2 Family caregivers administer medications (including opioid pain relievers); maintain equipment; and feed, bathe, and assist their family member with other activities of daily living. 2 Hospice patients in the United States have a prognosis of less than 6 months, and 40% are cared for in a private residence and require around-the-clock care. 1 It is extensively documented that caregiving takes a toll on family members who worry about performing tasks safely, especially when their care recipient is in pain. 2, 3 Family caregivers are often the most knowledgeable about the patient's condition and ultimately responsible for implementing all plans of care.
Hospice interdisciplinary teams meet every 2 weeks to develop a care plan for each patient. 4 The meetings required by Hospice Medicare Conditions of Participation are most often held in the local office of the hospice agency. The meetings will involve discussions of up to 100 patients and may last 3 to 4 hours. 4, 5 The purpose of these mandated meetings is to assure coordination of care and an interdisciplinary approach to symptom management. To effectively meet this goal, the teams focus their discussion on patients with problems and briefly update the status of patients without difficulties.
Unlike an inpatient setting, patient or family participation in care planning is uncommon in community-based hospice because of the physical condition of the patient and caregiving demands that prevent them from traveling. 5 This challenges the hospice philosophy, which advocates for patient and family participation in care. 4 To facilitate family and patient access to hospice care plan meetings, we completed a randomized controlled trial using web conferencing to facilitate patient and caregiver virtual attendance (Grant Number 5R01NR011472). The intervention was called Assessing Caregivers for Team Intervention via Video Encounters (ACTIVE). We hypothesized that caregivers' interactions with the team would improve their comfort with and perceptions of pain management.
This 4-year trial is one of very few randomized controlled trials in the hospice or palliative care setting focused on family caregivers. [6] [7] [8] [9] [10] [11] We asked the following research questions: (1) What is the effect of ACTIVE on caregivers' perceptions of pain management, caregiver's quality of life, caregiver's anxiety, and patient's pain? (2) Which caregivers benefit most from ACTIVE? (3) Is ACTIVE cost-effective? and (4) What are the facilitators and barriers to the future use of the ACTIVE intervention as reported by the informal caregivers and hospice staff?
Methods

Trial Design
A 2-group (usual care vs intervention) randomized controlled trial design was paired with a parallel mixed-methods analysis. A mixed methods approach was planned, providing both generalizable evidence and a deeper understanding of the findings. 12, 13 Details of the trial design, randomization, and intervention protocols are published elsewhere.
14 Briefly, upon admission into hospice, the nurse asked for permission for the research staff to contact the caregiver. Consenting patients were randomized into 2 equal groups using numbered, opaque, sealed envelopes in sequence. All caregivers for a particular patient received the same group assignment. Human participant's approval was obtained by the institutional review board of the University of Missouri Health Sciences. Written consent was obtained from caregivers, patients who were physically and cognitively able, and hospice staff members participating in the care conferences.
Participants and Setting
Family caregivers were recruited from 3 hospices in the Midwest. Participants were required to be designated as a primary caregiver for an enrolled hospice patient, over the age of 18 years, involved in decisions related to pain management, having access to a high-speed Internet connection or phone line, and without a hearing or cognitive impairment that would impair communication. Patients were required to be over 18 years and enrolled in a participating hospice. Patients with Palliative Performance Scale (PPS) scores below 30 at admission and their caregivers were excluded, as they were unlikely to survive to attend a meeting. 15, 16 Staff members were required to be employees of a participating hospice. Patients, when able, consented to the study and were encouraged to participate in the team meeting. If multiple caregivers were involved in the care decisions, all were offered the opportunity to participate.
Intervention
Details of the intervention and its protocols are detailed elsewhere.
14 In summary, following consent and group assignment, individuals in the intervention group were trained on the use of web conferencing and provided with a webcam. Participants without a computer joined the meeting with a telephone. The research staff established the connection and provided introductions, and the hospice team leader facilitated the discussion. Family members assigned to the intervention group were contacted by the research staff when it was their turn to be discussed. A speaker phone was used so all conversation was shared, and when web conferencing was used, both the family and group image were projected onto a central screen. An assigned hospice staff member (usually a nurse) would give a brief report on the patient's condition and identify any concerns for discussion. Family members were encouraged to provide feedback and ask questions before a final plan of care was agreed upon. Participants assigned to the usual care group were not a part of the discussion and did not provide input. Hospice staff could not be blinded to group assignment as it was obvious which caregivers attended the meetings. In both groups, research staff contacted participants every 2 weeks to collect measurement data. Control arm participants provided measurement data but otherwise received usual hospice care; they did not participate in any team meetings.
Outcomes
Based on our pilot work, the Caregiver Pain Medicine Questionnaire (CPMQ) was the primary outcome. 17 Scores on CPMQ items vary from 1 to 5, with lower scores indicating more problematic perceptions of pain management. The Caregiver Quality of Life Index-Revised (CQLI-R) 18 was collected as a secondary outcome. The CQLI-R consists of 4 domains (emotional, social, financial, and physical), each scored 0 to 10, with higher scores indicating higher quality of life. Patients or their caregiver proxies were asked to provide a numeric pain rating (0-10, higher scores indicating greater pain). After the first year of the trial, the Generalized Anxiety Disorder (GAD-7) 19 was added to measure caregiver's anxiety. Total scores for the GAD-7 range from 0 to 21, with higher scores representing more anxiety.
Interviews were conducted with caregivers 30 days following the death of their patient and with a convenience sample of staff on an annual basis. A semistructured interview guide was developed and tested in our pilot work and is available elsewhere. 1 and challenges with lost data due to death in our pilot study, 17 we collected outcome measures every 2 weeks for the first 4 weeks, every month through 6 months, and every 45 days thereafter. Research staff contacted participants by phone or provided a link to a Qualtrics (Provo, Utah) Internet-based survey.
Statistical Analysis
We powered the study at 80% to detect a difference in mean CPMQ score of 2.5 points on the 1 to 5 scale. Based on results from our pilot work, 17 we determined a sample size of 440 (220 in each group). Near the end of our trial, we analyzed the psychometric properties of the CPMQ. Despite its previously documented validity, the use of the instrument in a larger sample identified validity issues. 17, 21, 22 Validity improved with the elimination of 4 questions that were left out of all subsequent analyses.
All data were entered into a Microsoft Access database. Groups were compared at baseline according to demographic variables, setting, diagnosis, and other factors thought to be potential confounders. Two analyses were performed for each study outcome. The first analysis examined change from baseline to the last available measurement prior to death or the end of the study. The ''pre/post'' change was calculated for each participant, and the Wilcoxon rank sum test (WRST) was used to compare usual care and intervention groups with respect to changes. All randomized caregivers with at least 1 postbaseline measure were included in the analyses. The secondary analysis used a linear mixed model to test for group differences over time on the CPMQ, CQLI-R, and GAD-7 total scores. To account for the repeated-measures nature of the data and the varying duration of participation, both participant-specific intercept and slopes were treated as random effects. To minimize the leverage of a relatively small number of participants with extremely long follow-up times, we limited the number of days followed to 122, which was the 75th percentile of the days in the study for the combined sample. In addition to the CPMQ total score, we also used the WRST to compare groups with respect to change on 5 CPMQ subscales (fatalism, stoicism, concern about tolerance, concern about side effects, and concern about addiction). To test the effect of dose (number of team meetings a caregiver attended) on association with the overall CPMQ change, we used Spearman rank correlation coefficient. We similarly examined the secondary outcome variables.
Finally, a subgroup analysis was done to identify who might benefit most from the intervention in terms of the secondary outcomes. Although not powered to make definitive conclusions, we compared patient's pain, caregiver's anxiety, depression, and caregiver's perception of pain control by patient diagnosis (cancer vs other) using the WRST. Patient diagnosis and group (intervention vs usual care) were tested using generalized linear models. We identified a correlation between anxiety and patient's pain in the 2 diagnosis groups.
Qualitative Analysis
Qualitative data collection was conducted in parallel and with equal status as the quantitative measures. Data included observations, video recordings, and interviews with caregivers and staff. Several substudy analyses that were related to this study but had unique research questions are reported elsewhere. 20, [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] Our protocol required coders to achieve intercoder agreement of 80% or greater before independently coding data. Trustworthiness in analysis was assured through prolonged engagement, an extensive audit trail, multiple coders, and regular debriefing between all researchers. 35 
Merging Data
While the quantitative data provide numerical precision, the qualitative data represent a descriptive precision. The use of the matrix to combine the 2 sets of analysis by research question allows us compare interpretations and legitimate and explain our findings. 36 We used a parallel mixed analysis wherein both statistical and qualitative analyses were done separately and merged in the final analysis. The statistical analysis was done at the end of the study after all data had been collected. Various qualitative analyses with individual research questions were done throughout the project. In a final analysis, the statistical and various qualitative results were merged or mixed using a matrix for each research question. 36 Each matrix allowed for comparison and integration of all study results pertaining to the trial question. Within the matrix, themes were developed, summarized, and reviewed by all researchers. Finally, all research question results were combined into Table 1 .
Role of Funding Source
The National Institutes of Health had no role in the design and conduct of the study; the collection, management, analysis, and interpretation of the data; the preparation, review, or approval of the manuscript; or the decision to submit the manuscript for publication.
Results
We enrolled and collected data on 446 caregivers for 416 hospice patients between November 2010 and April 2014. The Consolidated Standards of Reporting Trials diagram (Figure 1 ) details participant recruitment, randomization, and dropout. There were no significant differences between those who agreed to study contact and those who did not regarding admission PPS score (P ¼ .33), time to death (P ¼ .59), and presence of cancer diagnosis (P ¼ .71). Demographics and baseline measures for the randomized groups are reported in Table 2 . Comparison of the groups found no significant differences except for income. Likewise, attrition and numbers of assessments were not significantly different between groups. The average number of There were no significant differences found in any of the measured primary or secondary outcomes for the trial. Table 3 presents the CPMQ, GAD-7, and CQLI-R scores by group. There were 357 (80%) caregivers with 2 or more scores. Change in total CPMQ score between the first and last available measures did not differ between groups (P ¼ .18). We found no evidence of association between the number of meetings attended (dose) and the change in the overall CPMQ score. The linear mixed model of repeated measures through 122 days postenrollment found no significant between-group differences in total CPMQ score or the rate of change between groups (group Â time interaction). There was also no statistically significant time effect. Likewise, no statistically significant effects were found with any secondary outcome. Analysis of CPMQ subscales identified 1 statistically significant association-fatalism-which improved more in the intervention group than in usual care (P ¼ .026). Fatalism is the belief that pain is inevitable and cannot be controlled. Relatedly, the interview question asking the caregiver's impression of pain control also differed between groups, as the intervention participants felt pain was better controlled (P ¼ .015).
In the mixed analysis, we found 3 themes that enhanced our understanding of caregiver's perceptions of pain (see Table 1 ). Team communication skills, caregiver knowledge, and psychosocial concerns were identified as influencing caregiver experiences and perceptions of pain. Table 4 details findings from the subanalysis. One third (n ¼ 126) of the patients had a cancer diagnosis. We found that patients with cancer had higher mean pain scores than noncancer patients; these differences approached statistical significance late in the hospice stay (P ¼ .077). Likewise, anxiety in caregivers of patients with cancer, although initially lower, increased toward the end of life, whereas noncancer caregivers' anxiety decreased; this difference also approached statistical significance (P ¼ .061). On exit interviews, caregivers of noncancer patients reported better pain control than caregivers of patients with cancer (P ¼ .015). Including both group and diagnosis in generalized linear models essentially parallels the mean comparisons. The correlation between caregivers' anxiety and patient's pain is .26 (P ¼ .044) for cancer caregivers compared with .15 (P ¼ .03) for noncancer caregivers, indicating a stronger correlation for cancer caregivers. Taken together, these findings demonstrate that pain is more intense, perceived to be more poorly managed, and more strongly associated with caregiver's anxiety for patients with cancer than others, suggesting that patients with cancer and their caregivers might be most appropriate for participation in the ACTIVE intervention, where it to be found to be effective in promoting pain control.
Which Caregivers Might Benefit Most From ACTIVE
The mixed analysis found that caregivers with specific communication patterns interact more with the team and had the potential for greater benefit. Caregivers with a tradition of fewer family hierarchical roles and a tendency toward more open conversation about death and dying were observed to be more adaptive, flexible, and process decisions and changes more easily with the hospice team.
Intervention Cost
The original cost-effectiveness analysis was not possible because there were no statistically significant outcomes (benefits) to weigh against the intervention costs. Thus, the analysis involved time cost only. When intervention caregivers participated in the meetings, discussions of their care recipient lasted an average of 6 minutes and ranged from 1 to 20 minutes. In contrast, discussions of the control group patients under usual care conditions (no participation by caregivers) lasted only 3 minutes and ranged between 1 and 11 minutes. Observational analysis of the meetings found 3 major reasons for the increased time: (1) a lack of knowledge by caregivers, especially related to pain issues, resulted in numerous questions, (2) a need for emotional support for caregivers resulted in lengthy supportive discussions (as long as 20 minutes), and (3) the lack of a strong facilitator. 34 
Facilitators and Barriers to Translation of ACTIVE Into Hospice Practice
Facilitators and barriers to the translation of ACTIVE into hospice were identified (Table 1) . Good team communication skills, technical quality of the web conferencing, and participant satisfaction were found to facilitate successful intervention. Facilitating communication skills included attention to caregiver literacy, awareness of both team and caregiver nonverbal communication, expression of empathy, active listening, and encouragement of questions from caregivers. Good (9) technical quality with the web conferencing facilitated nonverbal communication and a virtual presence that both caregivers and staff found important. Finally, translation can be facilitated if both caregivers and staff are receptive to the intervention and recognized benefits.
Team communication skills, technical quality, cost, and team structure and roles were identified as barriers to intervention. Specifically, a lack of attention to nonverbal communication of the team or caregiver impaired the interaction as caregivers felt ignored or disrespected. Likewise, when the pace of the discussion was too fast for caregivers to understand, caregivers reported no value. Second, audio problems in web conferencing sometimes impaired communication, creating frustration and lengthening the meeting. Third, cost (staff time) is a barrier to translation. Given the length of the meetings (up to 3-4 hours), an intervention that prolongs them is problematic. Finally, team structure and roles, specifically leadership style and absence of a family's usual nurse, can be a barrier. If caregivers do not see familiar faces, they are less likely to actively participate and reported frustration. Likewise, if the leader does not have a process to include everyone, frustration and inefficiency are evident.
Discussion
Pain management is one of the major challenges facing hospice caregivers. 7, 37, 38 Untrained caregivers are required to make complex pain assessments and administer powerful opioids with complicated administration schedules. [39] [40] [41] [42] The Institute of Medicine reports that 78% of family caregivers of patients with cancer are administering 5 to 9 medications per day, including opioids for pain. 3 Managing a dying patient's pain regimen is known to be filled with tremendous stress, as caregivers often believe they may have had hastened or caused their care recipient's death. 39, 40 Our pilot work found that including the ''faces and voices'' of informal caregivers and patients in team meetings, even for a short duration, resulted in collaborative interdependent goals between staff and patients/families, creating new activities and roles for patients/families within the team, requiring flexibility among individual members' role definitions. 17 Patient/family involvement resulted in collective ownership of all goals by team members, and the care outcomes could be evaluated through a reflection on the team process, again including feedback from patients/families. 43 Our hypothesis that caregivers' perceptions of pain could be changed was a result of these findings from our pilot work. The most frequent problem discussed by the team with the family involved pain, and the families most frequently noted benefit was an improved understanding of pain management. [43] [44] [45] Thus, the CPMQ was chosen as the primary outcome measure.
The analysis of the primary measure and the review of the qualitative analysis suggest explanations for the lack of statistical significance in our primary measure. Despite the success of the instrument in our pilot work 17 and the documented psychometrics in the development of the CPMQ, 22 our work with a larger sample indicates validity concerns. 17, 21, 22 We chose to investigate the validity of the instrument because of challenges reported by our research staff in collecting the responses from participants in this larger sample. Even when improving the validity with the elimination of 4 items, we conclude the instrument weaknesses may have impacted the detection of changes in caregiver's perception.
The qualitative analysis demonstrates that attendance at the care conferences does not always result in active participation. Likewise, active participation is not always constructive if the participation reflects a need for social support rather than a participation in a shared decision-making process. 35 Additional training of staff and caregivers around shared decision-making and participation may have improved the impact of the intervention.
Despite the lack of significance, the trial has much to offer. This rare multisite, multiyear trial provided the opportunity for in-depth longitudinal exposure in hospice with a robust sample to test a unique intervention. This trial was built with findings of a pilot study (Grant Number 5R01NR011472), which refined recruitment protocols, identified measures, and allowed sample size projections. We experienced limited recruitment or randomization challenges, unusual in this setting. 46 This trial found the intervention feasible, with generally acceptable technical quality and noted benefits. 27, 32 The mixed-methods analysis, rare in a randomized controlled design, 47 allowed hypothesis testing with statistical methods, whereas qualitative methods provided interpretation of findings, identified weaknesses in instrumentation, and suggested revisions in the intervention necessary for translation. This rather unique approach to clinical trials, in an area where instrumentation is known to have limitations, is advantageous in evaluating an intervention. 7, 17 The unique relationship of caregiver's anxiety and patient's pain is an interesting finding and can impact hospice care. Because medication is often controlled and administered by caregivers, their perceptions, knowledge, and emotions are critical in implementing hospice pain management plans. If the caregiver is uncomfortable with the pain regimen and does not appropriately assess pain and follow the plan of care, the patient could suffer, yet traditionally, little to no attention has been given to caregivers' perceptions, and they have had little opportunity for discussion and input on those plans. 48 This study demonstrates that involving caregivers in meetings where decisions and plans are made is feasible and has reported benefits. The finding that ACTIVE may be most helpful for caregivers of hospice patients with cancer is also important. Given the large number of hospice patient discussions in a meeting, focusing on those who may benefit the most would help manage the time and therefore cost of the intervention.
The study has limitations that impact its generalization and may explain the lack of statistical results. Given the nature of the intervention, the teams could not be blinded to group assignment as it was obvious who was and was not participating in the meetings. Although observation of the video recordings for control and intervention participants did not indicate that behavior of the team changed over time, we do not have a measure for this. Additionally, the challenges of validity with the CPMQ instrument may explain the lack of significant clinical findings. Likewise, it is noteworthy that this relatively rural homogeneous population limits the application to findings in more diverse hospice programs.
Conclusion
This study is significant despite the lack of statistically significant findings. To date, there have been only 10 randomized controlled trials in US hospices that focused on patient or caregiver outcomes. 11 Interdisciplinary team involvement in care planning and shared decision-making with patients and family members is gaining momentum within health care, and this intervention demonstrates feasibility in the community-based hospice setting. 49 Family caregivers, responsible for implementing plans of care in outpatient settings, are not a recognized part of the health-care system and too few interventions have been tested to improve their participation and recognition as partners in the care of terminally or critically ill patients. 6 Our qualitative findings show there is a need to support care plan meeting participation with education and emotional support outside the meeting. Examination of the questions asked by caregivers in this forum indicates a need for additional education, especially on pain management during routine hospice visits. Similarly, observation of needed emotional support during the interaction with the team suggests a need for additional psychosocial support from team members. Finally, our observations suggest that a more structured decision-making process led by a focused team leader may improve the time management of the meeting and thus the effectiveness of the intervention. 34 When the designated team leader did not manage time or participation proactively, the meeting went long, team members became frustrated, and the decision-making process was not effective. 34 Although ACTIVE aligns with the hospice philosophy of family-centered care and is a feasible way to involve family, it requires further refinement and testing to lower costs and more clearly quantify the benefits. Specifically, we believe the intervention needs to be enhanced with additional education and support of caregivers outside the team meeting and a structured focus decision-making process with a strong facilitator within the team meeting.
